tiprankstipranks
Terns Pharmaceuticals, Inc. (TERN)
:TERN
US Market

Terns Pharmaceuticals (TERN) Income Statement

Compare
377 Followers

Terns Pharmaceuticals Income Statement

Last quarter (Q3 2024), Terns Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Terns Pharmaceuticals's net income was $-21.95M. See Terns Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 1.00M$ 0.00$ 0.00
Gross Profit
$ -881.00K$ -1.03M$ 488.00K$ -394.00K$ -195.00K
Operating Expenses
$ 102.56M$ 62.03M$ 50.86M$ 37.02M$ 70.20M
Depreciation and Amortization
$ 292.00K$ 1.03M$ 512.00K$ 394.00K$ 195.00K
EBITDA
$ -102.27M$ -58.95M$ -49.35M$ -36.63M$ -35.00M
Operating Income
$ -102.56M$ -62.03M$ -49.86M$ -37.02M$ -70.20M
Other Income/Expenses
$ 12.59M$ 2.04M$ 210.00K$ -2.73M$ 1.36M
Pretax Income
$ -89.97M$ -59.99M$ -49.65M$ -39.76M$ -68.84M
Net Income
$ -90.21M$ -60.34M$ -50.16M$ -40.57M$ -68.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.27$ -1.67$ -1.98$ -1.61$ -2.74
Diluted EPS
$ -1.27$ -1.67$ -1.98$ -1.61$ -2.74
Weighted Average Shares Outstanding
71.26M 36.03M 25.27M 25.13M 25.10M
Weighted Average Shares Outstanding (Diluted)
71.26M 36.03M 25.27M 25.13M 25.10M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis